Congrats to Elisabeth Wilde, PhD & Carrie Esopenko, PhD! 👏
Elisabeth Wilde, PhD, and Carrie Esopenko PhD, have received a $4.6 million Department of Defense CDMRP.
The newly awarded Phase III clinical trial grant will investigate the therapeutic potential of photobiomodulation in individuals with chronic mild traumatic brain injury.